SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Tabula Rasa HealthCare, Inc. (TRHC) .
本页证实的标准:
- VALUE (10/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($3.00, 71.4%).
- 分析师共识目标价 $3.00 (-71.4% 下行风险) — 分析师认为当前价格水平存在明显下行风险。
SharesGrow 综合评分: 23/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
10/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — TRHC
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.85
EV/EBITDA0.0
每股数据
EPS (TTM)$-3.18
每股账面价值$0.00
每股营收$12.33
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$3.00 (-71.4%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS(稀释) |
营收 |
净利润 |
净利润率 |
| 2013 |
$-0.39 |
$25.14M |
$-3.87M |
-15.4% |
| 2014 |
$-0.11 |
$48.43M |
$-1.11M |
-2.3% |
| 2015 |
$-0.29 |
$70.04M |
$-2.86M |
-4.1% |
| 2016 |
$-0.54 |
$94.06M |
$-6.25M |
-6.6% |
| 2017 |
$0.68 |
$134.55M |
$14.3M |
10.6% |
| 2018 |
$-2.48 |
$204.27M |
$-47.27M |
-23.1% |
| 2019 |
$-1.57 |
$284.71M |
$-32.44M |
-11.4% |
| 2020 |
$-3.71 |
$297.22M |
$-80.97M |
-27.2% |
| 2021 |
$-3.39 |
$331.26M |
$-79.06M |
-23.9% |
| 2022 |
$-3.18 |
$299.52M |
$-77.33M |
-25.8% |